NCT04538612

Brief Summary

To estimate peripheral perfusion in shock state, international guidelines recommend the use of capillary refill time, and practitioners currently evaluates it at bedside. However its measurement is not standardized, what should explain the large observer variability reported in different studies. Hence, a device providing a standardized evaluation seems to be helpful. The aim of the study is to evaluate diagnostic performance of such a device recently developped (DiCART TM), in healthy volunteers experiencing vascular occlusion tests to induce impaired perfusion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 28, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 28, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 4, 2020

Completed
Last Updated

September 4, 2025

Status Verified

August 1, 2025

Enrollment Period

5 months

First QC Date

August 28, 2020

Last Update Submit

August 27, 2025

Conditions

Keywords

capillary refill timevascular occlusion testdeviceimpaired perfusionhealthy volunteers.

Outcome Measures

Primary Outcomes (1)

  • Capillary refill time on the thenar eminence evaluated with DiCART TM device.

    Diagnostic performance of DiCART TM device to detect a capillary refill time variation on the thenar eminence induced by a vascular occlusion test on the arm. DiCART TM measurement is fully automatized, and may be separated in three consecutive step : * An automatized cutaneous compression * A video acquisition of cutaneous recoloration * Data interpretation The investigators will compute Receptor Operative Characteristics curves with area under the curve, and will determine best threshold and grey zone to evaluate diagnostic performance of DiCART TM device to detect impaired perfusion.

    180 minutes

Secondary Outcomes (12)

  • Capillary refill time evaluated on the knee with DiCART TM device

    180 minutes

  • Intra -observer variability of capillary refill time measurement with DiCART TM device by performing repetitive measurements by two different investigators.

    180 minutes

  • Intra -observer variability of capillary refill time measurement with clinical method by performing repetitive measurements by two different investigators.

    180 minutes

  • Inter-observer variability of capillary refill time measurement with DiCART TM device by performing repetitive measurements by two different investigators.

    180 minutes

  • Inter-observer variability of capillary refill time measurement with clinical method by performing repetitive measurements by two different investigators.

    180 minutes

  • +7 more secondary outcomes

Study Arms (1)

measure capillary refill time

EXPERIMENTAL
Device: measure capillary refill time

Interventions

Each time, capillary refill time will be evaluated three times consecutively by clinical method applying a firm pressure with the finger during 15s, then brutally releasing it, and estimating time of skin recoloration with a chronometer and by DiCART TM device Three vascular occlusion tests will be successively performed with a cuff during less than 10 minutes: * Arterial vascular occlusion test (50mmHg above systolic arterial pressure of the healthy volunteers), * Veinous vascular occlusion test (30mmHg), * Control test without vascular occlusion test. Capillary refill time measurements will be repeated just before, during and just after vascular occlusion tests. Randomization determine the order of the vascular occlusion tests. Investigators performing capillary refill time evaluation will be blinded from it. Vascular occlusion tests will be alternatively performed by one and the other limb. The whole protocol will be performed at the upper and then at the lower limb.

measure capillary refill time

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers
  • Age \> 18 years old
  • Informed consent to participate

You may not qualify if:

  • Vascular disease
  • Diabetes mellitus
  • Dermatosis
  • Cutaneous lesion on a measurement site
  • Anemia
  • Pregnancy
  • Cardiovascular chronic treatment
  • Non affiliation to a social security regime
  • Involvement in other interventional study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Louis Pradel

Bron, France

Location

Related Publications (1)

  • Ruste M, Cazenave L, Tardif M, Saint-Jean C, Fellahi JL, Lagreze MJ. Measurement of capillary refill time with a handheld prototype device: a comparative validation study in healthy volunteers. J Clin Monit Comput. 2022 Oct;36(5):1271-1278. doi: 10.1007/s10877-021-00757-2. Epub 2021 Sep 22.

Study Officials

  • Matthias JACQUET-LAGREZE, MD

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
the investigators evaluate capillary refill time without knowing the status of vascular occlusion test.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2020

First Posted

September 4, 2020

Study Start

January 28, 2020

Primary Completion

July 10, 2020

Study Completion

July 10, 2020

Last Updated

September 4, 2025

Record last verified: 2025-08

Locations